Research progress on the treatment for aging lung transplantation recipients with cardiovascular disease
- VernacularTitle:合并心血管疾病的老年肺移植受者治疗的研究进展
- Author:
Guohui JIAO
1
,
2
;
Yating SHENG
1
,
2
;
Jingyu CHEN
1
,
2
Author Information
1. Wuxi People'
2. s Hospital Affiliated to Nanjing Medical University, Wuxi Organ Transplantation Institute, Jiangsu Lung Transplant Center, Wuxi, 214023, Jiangsu, P. R. China
- Publication Type:Journal Article
- Keywords:
Lung transplantation;
cardiac vascular disease;
valve disease;
survival;
prognosis;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(12):1671-1677
- CountryChina
- Language:Chinese
-
Abstract:
As the aging proceeds worldwide, aging lung transplantation recipients have been increased dramatically. Aging population with end-stage lung diseases also have comorbidities, such as cardiovascular disease, which may impact the prognosis of lung transplantation. Recent researches on lung transplantation have explored the characteristics of aging recipients, strategy selection on transplantation and cardiovascular disease management, as well as risk factors for post-transplantation complications and death. However, researches on lung transplantation recipients with cardiac valve disease are just in the initial stage. With the advancement of transcatheter technique, more patients will be benefited. We summarized the advancement in this field and took an outlook for future clinical researches.
